CJC-1295 + Ipamorelin

Description

CJC-1295 + Ipamorelin is supplied as a lyophilized dual-compound research blend for controlled laboratory investigation. The blend combines a modified GHRH analog with a selective ghrelin receptor agonist for preclinical models studying growth-hormone signaling dynamics, receptor selectivity, endocrine response markers, and pulsatile-release research endpoints.

Research positioning

This blend is intended for qualified laboratory research workflows only. It is not supplied for personal use, clinical use, compounding, human administration, veterinary administration, diagnosis, treatment, mitigation, or prevention of disease.

Product specifications

• Compounds: CJC-1295 + Ipamorelin
• Format: Lyophilized powder blend
• Testing: HPLC purity verification
• Storage: Refrigerated storage recommended at 2-8°C
• Intended use: Laboratory research only

Documentation

Batch documentation is available on request while the downloadable COA library is being finalized. Documentation may include batch reference, purity verification, testing method, release status, and storage guidance.

Research-use notice

For research use only. Not for human or veterinary use. Buyer is responsible for compliance with local laws, institutional rules, and applicable research ethics requirements.